Caption Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Caption Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,400	Closed	-$244K	–	1682
2021 Q1	$204K	Buy	+12,400	New	+$282K	﹤0.01%	917

Caption Management's TBIO Position: Q2 2021 in Review

Caption Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 12,400 shares — an estimated $244K sold.

Caption Management first reported a position in TBIO in Q1 2021 and held it in 1 quarter. The position peaked at $204K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

Caption Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Caption Management sold 12,400 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $244K.
Caption Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Caption Management's Translate Bio, Inc. Common Stock position peaked at $204K in Q1 2021.
145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Caption Management's 13F filing for Q2 2021, filed 16 Aug 2021.